131 related articles for article (PubMed ID: 2403290)
21. Metabolism of T-2 toxin by rat liver carboxylesterase.
Johnsen H; Odden E; Lie O; Johnsen BA; Fonnum F
Biochem Pharmacol; 1986 May; 35(9):1469-73. PubMed ID: 3707611
[TBL] [Abstract][Full Text] [Related]
22. Cresyl saligenin phosphate, an organophosphorus toxicant, makes covalent adducts with histidine, lysine, and tyrosine residues of human serum albumin.
Liyasova MS; Schopfer LM; Lockridge O
Chem Res Toxicol; 2012 Aug; 25(8):1752-61. PubMed ID: 22793878
[TBL] [Abstract][Full Text] [Related]
23. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
Maxwell DM
Toxicol Appl Pharmacol; 1992 Jun; 114(2):306-12. PubMed ID: 1609424
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
[TBL] [Abstract][Full Text] [Related]
25. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
Dettbarn WD; Yang ZP; Milatovic D
Chem Biol Interact; 1999 May; 119-120():445-54. PubMed ID: 10421482
[TBL] [Abstract][Full Text] [Related]
26. The effects of tri-o-cresyl phosphate and metabolites on rat Sertoli cell function in primary culture.
Chapin RE; Phelps JL; Burka LT; Abou-Donia MB; Heindel JJ
Toxicol Appl Pharmacol; 1991 Apr; 108(2):194-204. PubMed ID: 1902005
[TBL] [Abstract][Full Text] [Related]
27. Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds.
Saboori AM; Lang DM; Newcombe DS
Chem Biol Interact; 1991; 80(3):327-38. PubMed ID: 1954660
[TBL] [Abstract][Full Text] [Related]
28. The identification and characterization of two separate carboxylesterases in guinea-pig serum.
Cain K; Reiner E; Williams DG
Biochem J; 1983 Oct; 215(1):91-9. PubMed ID: 6626182
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of differential inhibition of hepatic and pancreatic fatty acid ethyl ester synthase by inhibitors of serine-esterases: in vitro and cell culture studies.
Kaphalia BS; Mericle KA; Ansari GA
Toxicol Appl Pharmacol; 2004 Oct; 200(1):7-15. PubMed ID: 15451303
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the delayed neurotoxicity of tributyl phosphate, tributoxyethyl phosphate, and dibutylphenyl phosphate.
Carrington CD; Lapadula DM; Othman M; Farr C; Nair RS; Johannsen F; Abou-Donia MB
Toxicol Ind Health; 1990; 6(3-4):415-23. PubMed ID: 2237927
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the delayed neurotoxic potential of isopropyl triphenylphosphate using a nontraditional testing strategy.
Sprague GL; Castles TR; Bickford AA
J Toxicol Environ Health; 1984; 14(5-6):773-88. PubMed ID: 6520887
[TBL] [Abstract][Full Text] [Related]
32. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
Shapira S; Kadar T; Cohen G; Chapman S; Raveh L
Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035
[TBL] [Abstract][Full Text] [Related]
33. The relationship between neurological damage and neurotoxic esterase inhibition in rats acutely exposed to tri-ortho-cresyl phosphate.
Padilla S; Veronesi B
Toxicol Appl Pharmacol; 1985 Mar; 78(1):78-87. PubMed ID: 2994253
[TBL] [Abstract][Full Text] [Related]
34. Low non-neuropathic tri-o-cresyl phosphate (TOCP) doses inhibit neuropathy target esterase near the neuropathic threshold in n-hexane pretreated hens.
Pellin MC; Vilanova E; Barril J
Toxicology; 1988 Apr; 49(1):99-105. PubMed ID: 3376128
[TBL] [Abstract][Full Text] [Related]
35. Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells.
Li W; Casida JE
Toxicol Lett; 1998 Sep; 98(3):139-46. PubMed ID: 9788582
[TBL] [Abstract][Full Text] [Related]
36. DNA adduct formation in Salmonella typhimurium, cultured liver cells and in Fischer 344 rats treated with o-tolyl phosphates and their metabolites.
Mentzschel A; Vamvakas S; Dekant W; Henschler D
Carcinogenesis; 1993 Oct; 14(10):2039-43. PubMed ID: 8222051
[TBL] [Abstract][Full Text] [Related]
37. Triphenyl phosphite neurotoxicity in the hen: inhibition of neurotoxic esterase and of prophylaxis by phenylmethylsulfonyl fluoride.
Carrington CD; Abou-Donia MB
Arch Toxicol; 1988; 62(5):375-80. PubMed ID: 3242448
[TBL] [Abstract][Full Text] [Related]
38. Carboxylesterases in rat and human sera and their relationship of serum aryl acylamidases and cholinesterases.
Tsujita T; Okuda H
Eur J Biochem; 1983 Jun; 133(1):215-220. PubMed ID: 6852027
[TBL] [Abstract][Full Text] [Related]
39. Estimation of the delayed neurotoxic potential and potency for a series of triaryl phosphates using an in vitro test with metabolic activation.
Sprague GL; Castles TR
Neurotoxicology; 1985; 6(1):79-86. PubMed ID: 3873039
[TBL] [Abstract][Full Text] [Related]
40. [A comparative study of the effect of vinyl phosphoric acid esters on cholinesterase and carboxylesterase activities in mammals and arthropods].
Kugusheva LI; Rozengart VI; Kozenasheva LIa; Kolesova VA
Zh Evol Biokhim Fiziol; 1990; 26(1):30-4. PubMed ID: 2360379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
